Literature DB >> 29878759

Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.

Bart I Roman1,2, Sigrid Verhasselt1, Christian V Stevens1,2.   

Abstract

( S)-Blebbistatin, a chiral tetrahydropyrroloquinolinone, is a widely used and well-characterized ATPase inhibitor selective for myosin II. The central role of myosin II in many normal and pathological biological processes has been revealed with the aid of this small molecule. The first part of this manuscript provides a summary of myosin II and ( S)-blebbistatin literature from a medicinal chemist's perspective. The second part of this perspective deals with the physicochemical deficiencies that trouble the use of ( S)-blebbistatin in advanced biological settings: low potency and solubility, fluorescence interference, (photo)toxicity, and stability issues. A large toolbox of analogues has been developed in which particular shortcomings have been addressed. This perspective provides a necessary overview of these developments and presents guidelines for selecting the best available analogue for a given application. As the unmet need for high-potency analogues remains, we also propose starting points for medicinal chemists in search of nanomolar myosin II inhibitors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29878759     DOI: 10.1021/acs.jmedchem.8b00503

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Positional Isomers of a Non-Nucleoside Substrate Differentially Affect Myosin Function.

Authors:  Mike Woodward; Eric Ostrander; Seung P Jeong; Xiarong Liu; Brent Scott; Matt Unger; Jianhan Chen; Dhandapani Venkataraman; Edward P Debold
Journal:  Biophys J       Date:  2020-06-30       Impact factor: 4.033

2.  Synthesis and Evaluation of 4-Hydroxycoumarin Imines as Inhibitors of Class II Myosins.

Authors:  Jhonnathan Brawley; Emily Etter; Dante Heredia; Amarawan Intasiri; Kyle Nennecker; Joshua Smith; Brandon M Welcome; Richard K Brizendine; Thomas W Gould; Thomas W Bell; Christine Cremo
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

3.  MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis.

Authors:  Pratima Nangia-Makker; Malathy P V Shekhar; Victor Hogan; Vitaly Balan; Avraham Raz
Journal:  Oncotarget       Date:  2022-03-14

Review 4.  Excitation-contraction coupling in mammalian skeletal muscle: Blending old and last-decade research.

Authors:  Pura Bolaños; Juan C Calderón
Journal:  Front Physiol       Date:  2022-09-02       Impact factor: 4.755

5.  Active force generation contributes to the complexity of spontaneous activity and to the response to stretch of murine cardiomyocyte cultures.

Authors:  Seyma Nayir; Stéphanie P Lacour; Jan P Kucera
Journal:  J Physiol       Date:  2022-06-23       Impact factor: 6.228

Review 6.  Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options.

Authors:  Cristian Stătescu; Ștefana Enachi; Carina Ureche; Laura Țăpoi; Larisa Anghel; Delia Șalaru; Carmen Pleșoianu; Mădălina Bostan; Dragoș Marcu; Mircea Ovanez Balasanian; Radu Andy Sascău
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

Review 7.  Myosin Motors: Novel Regulators and Therapeutic Targets in Colorectal Cancer.

Authors:  Nayden G Naydenov; Susana Lechuga; Emina H Huang; Andrei I Ivanov
Journal:  Cancers (Basel)       Date:  2021-02-11       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.